Hint mode is switched on Switch off
For swift navigation between sections

International bonds: AMAG Pharmaceuticals, 7.875% 1sep2023, USD (USU02078AA87)

Download
Copy issue information to clipboard
Copy issue information to clipboard
Copy to clipboard
Data copied to the clipboard
PDF download
Choose all Reset all
Download Cancel

Status
Early redeemed
Amount
500,000,000 USD
Placement
***
Early redemption
*** (-)
ACI on
Country of risk
USA
Current coupon
-
Price
-
Yield / Duration
-
Calculate in two clicks! yield, duration and other parameters
Calculate in two clicks! yield, duration and other parameters
Calculator What is a calculator?
  • Placement amount
    500,000,000 USD
  • Minimum Settlement Amount
    1,000 USD
  • ISIN RegS
    USU02078AA87
  • CFI RegS
    DBFUGR
  • FIGI RegS
    BBG009S7L0B8
  • Ticker
    AMAG 7.875 09/01/23 REGS

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Trading chart

Stock exchange selection
Stock exchange selection
More about Cbonds Estimation
Bond is not traded; the issue is redeemed
Data display in a chart | table
Data display in a chart | table
Work with the chart: switching the price, period, issue comparison
Work with the chart: switching the price, period, issue comparison
Customize fields in the table
Found:
Show all fields
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
* Data is not available within the selected subscription
Quotes from market participants are indicative

Stock exchange and OTC quotes

Quotes provided by information providers are indicative in nature

Issue information

Profile
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia (IDA). The Company markets and sells Feraheme in the United States through its ...
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia (IDA). The Company markets and sells Feraheme in the United States through its own commercial organization. Feraheme is approved for use in the treatment of both dialysis and non-dialysis dependent chronic kidney disease (CKD) patients. The Company’s principal source of revenue is from the sale of Feraheme (ferumoxytol) Injection for intravenous (IV). In December 2011, Feraheme was also granted marketing approval in Canada for use as an IV iron replacement therapy for the treatment of IDA in adult patients with CKD. GastroMARK, which is marketed and sold under the trade name Lumirem outside of the United States, is the Company’s oral contrast agent used for delineating the bowel in magnetic resonance imaging (MRI), and is approved and marketed in the United States, Europe, and other countries through its licensees.
Show more Hide
  • Borrower
    Go to the issuer page
    AMAG Pharmaceuticals
  • Full borrower / issuer name
    AMAG Pharmaceuticals
  • Sector
    Corporate
  • Industry
    Pharmaceutical Preparation and Biotechnology
Volume
  • Placement amount
    500,000,000 USD
Face value
  • Minimum Settlement Amount
    1,000 USD
  • Outstanding face value
    *** USD
  • Increment
    *** USD
  • Face value
    1,000 USD
Listing
  • Listing
    ***

Cash flow parameters

  • Reference rate
    ***
  • Coupon Rate
    ***
  • Day count convention
    ***
  • Interest Accrual Date
    ***
  • Coupon frequency
    *** time(s) per year
  • Payment currency
    ***
  • Maturity date
    ***
  • Early redemption date
    ***

Cash flow

Calculations for international bonds are made according to the minimum trading lot
Export to Excel

Early redemption terms

***

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Placement

  • Placement method
    Open subscription
  • Placement type
    Public
  • Placement
    ***
  • Initial issue price (yield)
    (***%)
  • Geographic breakdown
    ***
  • Investor breakdown
    ***
Participants
  • Bookrunner
    ***, ***
  • Depository
    ***

Conversion and exchange

  • Conversion terms
    ***

Additional information

Latest issues

Show all

News

17/10/2018 Moody's Investors Service withdrew LT- foreign currency credit rating for AMAG Pharmaceutical
01/10/2018 S&P Global Ratings withdrew Local Currency LT credit rating for AMAG Pharmaceutical
01/10/2018 S&P Global Ratings withdrew Foreign Currency LT credit rating for AMAG Pharmaceutical
01/02/2018 S&P Global Ratings downgrades Local Currency LT credit rating of AMAG Pharmaceutical to "B"; outlook stable
01/02/2018 S&P Global Ratings downgrades Foreign Currency LT credit rating of AMAG Pharmaceutical to "B"; outlook stable
All organization news

IFRS/US GAAP reports

2020
I q eng
II q eng
III q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide
Authorization required
You need to request access

Identifiers

  • ISIN RegS
    ***
  • ISIN 144A
    ***
  • CUSIP RegS
    ***
  • CUSIP 144A
    ***
  • CFI RegS
    DBFUGR
  • CFI 144A
    DBFUGR
  • FIGI RegS
    BBG009S7L0B8
  • FIGI 144A
    BBG009R4DK49
  • WKN RegS
    A1Z5EY
  • WKN 144A
    A1Z5DZ
  • Ticker
    AMAG 7.875 09/01/23 REGS
  • Type of security by CBR
    ***
Show more Hide

Bond classification

  • Rank: Undefined
  • Registered
  • Documentary bonds
  • Coupon bonds
  • Amortization
  • Callable
  • CDO
  • Convertible
  • Dual currency bonds
  • Variable rate
  • For qualified investors (CIS region)
  • Foreign bonds
  • Green bonds
  • Guaranteed
  • Inflation-linked principal
  • Supranational bond issues
  • Inflation-linked coupon
  • Mortgage bonds
  • Perpetual
  • Payment-in-kind
  • Non-Marketable Securities
  • Redemption Linked
  • Restructuring
  • Retail bonds
  • Covered
  • Securitization
  • Structured product
  • Commercial Bonds
  • Subordinated
  • Sukuk
  • Trace-eligible
Show more Hide

Restructuring

***

Registration is required to get access.